Trials / Sponsors / OncoSil Medical Limited
OncoSil Medical Limited
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy Locally Advanced Pancreatic Adenocarcinoma | — | 2024-05-30 |
| Active Not Recruiting | FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcino Locally Advanced Pancreatic Cancer | Phase 2 | 2023-04-26 |
| Recruiting | OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. Pancreatic Neoplasm, Digestive System Neoplasm, Neoplasms by Site | — | 2022-04-12 |
| Completed | A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel Unresectable Locally Advanced Pancreatic Carcinoma | N/A | 2017-08-01 |
| Completed | A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abra Unresectable Locally Advanced Pancreatic Carcinoma | N/A | 2017-03-27 |